Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to assess the safety and efficacy of UNI91103 intranasal spray for treatment of coronavirus disease 2019 (COVID-19) in asymptomatic or mildly symptomatic adults.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
None of the symptoms should have been present >5 days.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
4 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal